Nathan Rich

Stock Analyst at Goldman Sachs

(0)
# 4100
Out of 5,293 analysts
96
Total ratings
36.36%
Success rate
-8.36%
Average return
21 Stocks
Name Action Price Target Current % Upside Ratings Updated
OSCR Oscar Health
Maintains: Neutral
16 21
12.98 61.79% 6 May 9, 2024
ZTS Zoetis
Maintains: Buy
223 196
161.79 21.14% 8 May 6, 2024
XRAY Dentsply Sirona
Maintains: Neutral
34 30
14.64 104.92% 8 May 6, 2024
AMRX Amneal Pharmaceutica...
Maintains: Strong Buy
7 8
8.23 -2.79% 7 May 6, 2024
NVST Envista Holdings
Maintains: Sell
20 18
17.09 2.4% 4 May 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
450 385
264.4 45.61% 7 Apr 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
13 14
10.36 35.14% 9 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
10 11
15.3 -28.1% 4 Feb 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
197 225
158.02 42.39% 2 Feb 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
500 650
418.57 55.29% 3 Jan 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
35 30
31.27 -4.06% 4 Dec 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
350 300
1.38 21639.13% 8 Nov 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
100 88
67.94 29.53% 6 May 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 12
18.18 -33.99% 6 Apr 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
93 85
69.02 23.15% 1 Jul 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
18 16
n/a n/a 1 May 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
10 11
8.58 28.21% 3 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
280 240
n/a n/a 3 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
335
327.17 2.39% 1 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
535
523 2.29% 4 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
10
n/a n/a 1 Dec 18, 2019